Johnson & Johnson Seeks EMA Approval to Extend AKEEGA Use for Prostate Cancer Read More » July 3, 2025
Transition of Promotional Activities for Allergen Immunotherapy Drug Actair in Japan Read More » July 3, 2025
Redhill Biopharma Starts Recruitment For Phase 2 Opaganib/darolutamide Combo Study In Advanced Prostate Cancer Read More » July 2, 2025
LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations Read More » June 25, 2025
